WEARING A MASK IS STILL REQUIRED TO ENTER SUNNYBROOK. VISITORS AND PATIENTS MUST ALSO BE ASYMPTOMATIC & SHOULD BE FULLY VACCINATED. »

Hospital  >  Welcome  >  Calendar of Events  >  Events
Share:  
|

Creating a Winning Funding Proposition & Raising Capital

When: Tuesday, March 15, 2022 4:30 p.m. - 7:00 p.m.

The process of raising funds and getting support from different healthcare stakeholders for your medical device technology can be frustrating and stressful. Knowing how to put together a strong funding or business case proposal for your technology is key to your success.

In the first part of this session, Stefano Picone will discuss the process of business development and essential elements required in a good business case or early stage pitch for a medical device innovation drawing on his experience in the medical technology sector.

In the second part of the session, Dr. Gary Gershony will discuss (i) Criteria for evaluating business opportunities in healthcare/medtech; (ii) What investors are looking for in a pitch and how this information fit within the investor's overall due diligence process; and (iii) top mistakes entrepreneurs make when pitching.

Guest Speakers:

Stefano Picone has over a decade of experience in the medical technology industry. He is the Vice President of Finance & Business Development for Conavi Medical, which is a commercial-stage medical device company focused on intracoronary imaging. Stefano is also on the Board of Xpan Medical, which is an early-stage company developing access ports for minimally invasive surgery and serves on the Commercialization Advisory Committee of the Holland Bloorview Research Institute. He is a member of the Chartered Professional Accountants of Ontario and a graduate of the University of Toronto. In his personal time, he enjoys spending time with family, Notre Dame football and chess!

Dr. Gershony graduated from the University of Toronto Medical School where he also completed his training in general cardiology. He subsequently completed a fellowship in interventional cardiology at Emory University under Andreas Grüntzig, the inventor of angioplasty. From 1993-1997 he was Director of the Cardiac Cath Lab and Interventional Cardiology at UC Davis. Since 1999 he has practiced interventional cardiology at John Muir Cardiovascular Institute in the Bay Area where he is currently Director of Cardiovascular Research, Education and Technology, and has established a successful TAVR program. Dr. Gershony is board certified in general and interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association, and the Society for Cardiovascular Angiography and Interventions. He has authored over 100 manuscripts and abstracts in the field of cardiology and is a regularly invited faculty lecturer to the preeminent U.S. and international interventional cardiology conferences. Dr. Gershony was the Founder of Vascular Solutions (VASC), which had a successful IPO in 2000, and for which he served as CMO and a member of the BOD from 1996-2002. He was the principal inventor of the Duett™ Vascular Sealing Device manufactured by Vascular Solutions. Dr. Gershony was also the Co-Founder and CMO of AngioScore, which has developed unique scoring balloon catheters for coronary and peripheral angioplasty procedures. He was a member of the senior management team from 2003 until AngioScore’s successful acquisition by Spectranetics (SPNC) in 2014. Dr Gershony is a founding General Partner of BayMed Venture Partners, a venture capital fund focused on maturing early stage Medical Device and Digital Health companies located in North America and Israel. Dr. Gershony has served on the adjunct faculty of the Stanford Biodesign Innovation Program. He is the author of 11 issued medical device patents. He has been a member of the scientific advisory board or a consultant to numerous medical device companies and venture capitalists in the Bay Area and elsewhere.

Learn more and register »